Therapeutic uses of the hypervariable region of monoclonal...

Details Therapeutic uses of the hypervariable region of monoclonal... Therapeutic uses of the hypervariable region of monoclonal...

C - Chemistry, Metallurgy

12

P

C12P 21/08 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) A61K 51/10 (2006.01) C07K 16/30 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2072017

2072017 9109058 PCTABS00005 Therapeutic agents and methods for treating and diagnosing leukemia are provided. Such agents comprise monoclonal antibody M195, a polypeptide capable of binding to the antigen of M195, or a chimeric antibody such as a peptide, conjugated to a cytotoxic agent, e.g. a radioisotope or alone. Methods for delivering genetic information to a targeted cell is also provided.

Affiliated with

Also associated with

Rating

Therapeutic uses of the hypervariable region of monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of the hypervariable region of monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of the hypervariable region of monoclonal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1654743